Simplex Trading
SPRY icon

Simplex Trading’s ARS Pharmaceuticals SPRY Stock Holding History

Simplex Trading’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.62K Sell
700
-38,300
-98% -$367K ﹤0.01% 7809
2025
Q4 		$454K Sell
39,000
-12,700
-25% -$124K ﹤0.01% 3394
2025
Q3 		$519K Buy
51,700
+45,000
+672% +$646K ﹤0.01% 3780
2025
Q2 		$116K Sell
6,700
-86,400
-93% -$1.25M ﹤0.01% 5093
2025
Q1 		$1.17M Buy
93,100
+79,100
+565% +$952K ﹤0.01% 2548
2024
Q4 		$147K Sell
14,000
-11,000
-44% -$154K ﹤0.01% 4805
2024
Q3 		$362K Buy
25,000
+15,300
+158% +$182K ﹤0.01% 3937
2024
Q2 		$82K Buy
9,700
+4,600
+90% +$40.8K ﹤0.01% 5579
2024
Q1 		$52K Sell
5,100
-16,200
-76% -$121K ﹤0.01% 6228
2023
Q4 		$116K Sell
21,300
-211,100
-91% -$925K ﹤0.01% 5235
2023
Q3 		$878K Buy
232,400
+192,200
+478% +$1.26M ﹤0.01% 2803
2023
Q2 		$269K Buy
40,200
+25,600
+175% +$171K ﹤0.01% 3963
2023
Q1 		$95K Buy
+14,600
New +$112K ﹤0.01% 5208
2022
Q4 		– Sell
-19,700
Closed -$104K – 10351
2022
Q3 		$104K Sell
19,700
-465,100
-96% -$2.29M ﹤0.01% 5471
2022
Q2 		$2.06M Buy
484,800
+483,800
+48,380% +$1.69M ﹤0.01% 1839
2022
Q1 		$3K Buy
+1,000
New +$4.35K ﹤0.01% 9741

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Simplex Trading's SPRY Position: Q2 2025 in Review

Simplex Trading sold out of ARS Pharmaceuticals (SPRY) in Q2 2025, closing a stake of 44,092 shares — an estimated $636K sold.

Simplex Trading first reported a position in SPRY in Q4 2021 and held it in 8 quarters. The position peaked at $806K in Q3 2024. 187 funds tracked by Wall St. Rank hold SPRY as of Q2 2025.

  • Simplex Trading reported no remaining ARS Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 44,092 ARS Pharmaceuticals shares in Q2 2025, an estimated $636K.
  • Simplex Trading first reported a position in ARS Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Simplex Trading's ARS Pharmaceuticals position peaked at $806K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.